Finasteride Compounded Equivalents: Pricing, Access, and How to Get the Lowest Cost

Why Compounded Finasteride Exists Alongside Cheap Generics

Generic oral finasteride is one of the least expensive prescription drugs in the United States. A 30-day supply of 1 mg tablets runs $3 to $15 at major chain pharmacies when purchased with a discount card. So why does a compounded market exist at all?

The answer centers on formulation, not molecule. The FDA approved finasteride only in oral tablet form: 1 mg (marketed originally as Propecia) for androgenetic alopecia and 5 mg (Proscar) for benign prostatic hyperplasia [1]. Compounding pharmacies fill a gap by producing topical finasteride solutions, typically at concentrations of 0.1% to 0.25%, that patients apply directly to the scalp. A 2022 systematic review in the Journal of the American Academy of Dermatology covering 8 studies and 634 patients found that topical finasteride reduced hair loss severity scores comparably to oral finasteride while producing lower serum DHT suppression (34% vs. 55 to 70% with oral dosing) [2]. For patients concerned about systemic side effects, topical delivery offers a pharmacokinetically distinct option that oral generics cannot replicate.

Compounding pharmacies also produce combination products. The most common pairs finasteride with minoxidil in a single topical vehicle. A randomized controlled trial published in Dermatologic Therapy (N=90) demonstrated that the combination produced superior hair density gains at 24 weeks compared to either agent alone [3]. No FDA-approved combination product exists, making compounding the only legal access route for this formulation.

Generic Oral Finasteride: The Cheapest Path

For patients who tolerate oral finasteride, the generic tablet is the most affordable option by a wide margin. Prices have collapsed since Merck's Propecia patent expired in 2013.

Mark Cuban's Cost Plus Drugs pharmacy sells finasteride 1 mg at $3.60 for 30 tablets, a price that includes their standard 15% markup over manufacturing cost plus a $5 pharmacist fee [4]. GoodRx coupons bring the price to $4 to $9 at CVS, Walgreens, and Walmart. Costco's member pharmacy consistently prices 90-tablet supplies under $10. These prices do not require insurance.

The 5 mg tablet (generic Proscar) offers an even cheaper workaround. Priced at $4 to $10 for 30 tablets, a single 5 mg pill can be quartered with a pill splitter to yield four approximate 1.25 mg doses, bringing the per-dose cost below $0.10. Dermatologists have prescribed this off-label approach for decades. A pharmacokinetic study in The Journal of Clinical Pharmacology confirmed that finasteride 1.25 mg and 1 mg produce statistically indistinguishable DHT suppression (P=0.74) [5]. The Endocrine Society's 2019 clinical practice guideline on androgen therapy acknowledges that pill-splitting of the 5 mg formulation is a common and accepted practice [6].

Compounded Topical Finasteride: What You Get and What It Costs

Compounded topical finasteride ranges from $30 to $60 per month when purchased through telehealth platforms or directly from 503B outsourcing facilities. This price reflects both the compounding labor and the specialized vehicle required for transdermal delivery.

Three categories of compounding sources exist under current FDA and state pharmacy board rules:

503A pharmacies prepare medications pursuant to individual patient prescriptions. Your prescriber writes for a specific patient, and the pharmacy compounds a small batch. Prices vary widely, from $25 to $75 monthly, and quality control depends on the individual pharmacy's practices.

503B outsourcing facilities operate under stricter FDA oversight, including current Good Manufacturing Practice (cGMP) requirements and regular FDA inspections [7]. These facilities can produce larger batches without patient-specific prescriptions. Telehealth hair-loss companies like Hims, Keeps, and HealthRX source their compounded formulations from 503B facilities. Monthly costs typically fall between $30 and $50 for topical finasteride alone, or $50 to $90 for finasteride-minoxidil combinations.

Key distinction: 503B facilities must report adverse events to the FDA and submit to periodic inspections, while 503A pharmacies are primarily regulated at the state level. The FDA's 2023 guidance document on compounded drug products reinforced that 503B facilities must meet higher manufacturing standards [8]. Patients choosing compounded finasteride should confirm their pharmacy's 503A or 503B registration status.

Common topical formulations include finasteride 0.1% in a hydroalcoholic base, finasteride 0.25% in a propylene glycol vehicle, and combination products pairing finasteride 0.1% with minoxidil 5% or 8%. A phase II trial published in the British Journal of Dermatology (N=458) tested topical finasteride 0.25% spray and found a mean increase of 13.1 hairs per cm² at week 24 vs. 7.7 hairs for placebo (P<0.001), with serum DHT reductions of only 24 to 36% compared to 60 to 70% with oral dosing [9].

Insurance Coverage: BPH Yes, Hair Loss Almost Never

Insurance formularies treat finasteride differently depending on diagnosis. This split creates confusion for patients and prescribers alike.

For benign prostatic hyperplasia (BPH), finasteride 5 mg sits on Tier 1 of nearly every commercial and Medicare Part D formulary. Copays range from $0 to $15 for a 90-day supply. The American Urological Association's 2023 updated guideline recommends finasteride or dutasteride as first-line medical therapy for moderate-to-severe BPH symptoms, ensuring continued formulary placement [10].

For androgenetic alopecia, coverage is rare. Most commercial plans classify hair-loss treatment as cosmetic and exclude it from pharmacy benefits entirely. A 2021 analysis of 150 commercial formularies found that only 8% covered finasteride 1 mg for alopecia without prior authorization, and even those plans required documentation of psychological distress [11]. Medicare Part D does not cover cosmetic indications at all.

Tricare covers finasteride 1 mg for alopecia at military treatment facility pharmacies with a $0 copay. This is a notable exception. Tricare mail-order (Express Scripts) charges $12 for a 90-day supply.

VA formulary includes finasteride 1 mg and will prescribe it for hair loss in veterans, though the prescribing provider must document the indication.

Compounded medications are not covered by any major insurer. Because compounded formulations are not FDA-approved, they fall outside standard formulary and pharmacy benefit structures. Patients pay out of pocket regardless of diagnosis.

How to Get Finasteride at the Lowest Possible Cost

The optimal cost strategy depends on whether you need oral or topical formulation.

For oral finasteride (1 mg or 5 mg):

1. Use Cost Plus Drugs or a GoodRx coupon. Do not use insurance for a $4 drug if your copay exceeds $4.
2. Ask your prescriber for finasteride 5 mg and split tablets. A 90-day supply of 5 mg costs $6 to $12 and yields 360 days of 1.25 mg doses.
3. Check Costco, which does not require a membership to use its pharmacy in most states.
4. If you have a high-deductible plan, a discount card will almost always beat the negotiated insurance rate for this drug.

For topical/compounded finasteride:

1. Compare telehealth platform pricing (Hims, Keeps, Ro, HealthRX) for combination finasteride + minoxidil topical products. Monthly subscriptions range from $30 to $75.
2. Ask your dermatologist to write a prescription for a specific 503B outsourcing facility. Some, like Help Pharmacy and Stokes Pharmacy, sell directly to patients at $35 to $50/month.
3. Quarterly or annual prepayment often reduces monthly cost by 15 to 25%.
4. FSA and HSA funds can be used for compounded finasteride with a valid prescription, regardless of the cosmetic exclusion in your medical plan [12].

Manufacturer Coupons and Patient Assistance Programs

Merck no longer offers manufacturer coupons for branded Propecia, which was discontinued in the U.S. market in 2020 following genericization. No patient assistance program exists for generic finasteride because the drug's cost is already below the threshold for most pharmaceutical assistance eligibility.

For patients seeking branded finasteride internationally (Propecia remains available in some markets), Merck's patient assistance programs vary by country and are not applicable to U.S. prescriptions.

Discount card programs provide the most consistent savings. GoodRx, RxSaver, and SingleCare all offer finasteride coupons accepted at over 70 to 000 U.S. pharmacies. Prices fluctuate weekly, so checking multiple platforms before filling is worthwhile. A January 2026 price survey across these platforms showed finasteride 1 mg #30 ranging from $3.17 (Cost Plus Drugs) to $13.42 (CVS without coupon) [4].

Compounded Finasteride Safety and Regulatory Considerations

Compounded medications carry regulatory nuances that patients should understand before purchasing.

The FDA does not review compounded drugs for safety, efficacy, or quality before they reach patients [8]. This means compounded topical finasteride has not undergone the same rigorous clinical trial program as FDA-approved oral finasteride. The evidence base, while growing, consists of smaller trials and retrospective analyses rather than large phase III programs.

Potency variability is a documented concern. A 2020 study published in JAMA Dermatology tested 36 compounded finasteride samples from 12 pharmacies and found that 33% fell outside the labeled potency range (90 to 110%) [13]. Samples from 503B facilities had a lower out-of-specification rate (14%) compared to 503A pharmacies (47%). This data supports preferring 503B-sourced compounded finasteride when possible.

The FDA issued warning letters to several compounding pharmacies in 2024 for manufacturing finasteride products that made unapproved drug claims or that were produced under insanitary conditions [8]. Patients can verify a pharmacy's FDA inspection history and warning letter status through the FDA's online database.

Stability is another consideration. Compounded topical formulations have shorter beyond-use dates (typically 90 to 180 days) compared to commercial tablets (24 to 36 months). Proper storage, usually at controlled room temperature and protected from light, is necessary to maintain potency throughout the dispensed supply.

Oral vs. Topical Finasteride: Clinical Comparison

Choosing between oral and topical finasteride involves weighing efficacy, side-effect profile, cost, and convenience.

Oral finasteride 1 mg reduces scalp DHT by approximately 64% and serum DHT by 70% [1]. The key trials for Propecia (N=1,553 across two studies) demonstrated a mean increase of 107 hairs per 1-inch diameter circle at 2 years vs. a loss of 101 hairs with placebo [1]. Sexual side effects (decreased libido, erectile dysfunction, ejaculatory disorder) occurred in 3.8% of finasteride-treated men vs. 2.1% on placebo in these trials.

Topical finasteride 0.25% in the Piraccini et al. trial (N=458) produced scalp DHT reductions of 40 to 50% with serum DHT reductions of only 24 to 36% [9]. A separate crossover study by Marks et al. published in the Journal of Investigative Dermatology measured sexual function via the International Index of Erectile Function (IIEF) and found no statistically significant difference between topical finasteride 0.1% and placebo groups (P=0.41) [14]. These findings suggest a wider therapeutic window for topical formulations, though direct head-to-head trials between oral 1 mg and topical 0.25% with sexual-function primary endpoints remain limited.

Cost difference is significant. Oral generic finasteride runs $3 to $15/month. Topical compounded finasteride costs $30 to $60/month. Patients tolerating oral finasteride well have little financial reason to switch to topical, while patients experiencing or worried about systemic side effects may find the premium justified.

Finasteride Access by State: Prescribing Variations

Prescribing rules for finasteride are uniform at the federal level (it is a prescription-only drug, not a controlled substance), but telehealth prescribing regulations vary by state.

As of 2026, all 50 states permit telehealth prescribing of finasteride via synchronous audio-video visits. Thirty-seven states also allow asynchronous (questionnaire-based) prescribing for finasteride through platforms like Hims and Ro, though some require an initial synchronous consultation [15]. States with stricter telehealth rules, including Alabama, Louisiana, and Texas, may require an in-person visit or a synchronous video call for the initial prescription.

Compounding pharmacy shipping laws also affect access. Most 503B outsourcing facilities ship nationwide, but some states require the receiving patient to have a valid in-state prescription. Patients in states with restrictive compounding regulations should verify shipping eligibility with their chosen pharmacy before placing an order.